Cargando…

BASELINE CHARACTERISTICS AND PREDICTORS FOR ALL-CAUSE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

Detalles Bibliográficos
Autores principales:	CHAROENPONG, PRANGTHIP, MOTAYAR, NASIM, SONG, DIANA, FORD, DEON, DAOUD, NOUR, ADEDEJI, ADEKOLA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503422/ http://dx.doi.org/10.1016/j.chest.2021.07.554

Ejemplares similares

BASELINE CHARACTERISTICS AND MORTALITY IN PATIENTS WITH SARS-COV-2 CONFIRMED INFECTION: SINGLE MAJOR ACADEMIC CENTER EXPERIENCE
por: Uribe, Juan Pablo, et al.
Publicado: (2020)

PREDICTOR VARIABLES FOR MORTALITY IN THE 48 HOURS PRIOR TO ENDOTRACHEAL INTUBATION IN PATIENTS WITH COVID-19 PNEUMONIA
por: SHER, NEHAN, et al.
Publicado: (2021)

COVID-19-RELATED GUILLAIN–BARRÉ SYNDROME: A CASE SERIES
por: RODRIGUEZ ROSA, AXEL, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOME OF PNEUMOMEDIASTINUM AND PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA
por: RANA, VISHAL, et al.
Publicado: (2021)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

EFFECT OF A MULTIDISCIPLINARY FOLLOW-UP PROGRAM ON LONG-TERM, ALL-CAUSE MORTALITY IN VETERAN SURVIVORS OF COVID-19
por: AUNG, YE, et al.
Publicado: (2022)

IMPACT OF ADMISSION TROPONIN AND TROPONIN RISE DURING HOSPITALIZATION ON MORTALITY IN COVID-19 PNEUMONIA WITH ACUTE RESPIRATORY FAILURE
por: GUPTA, MANASVI, et al.
Publicado: (2021)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB
por: Proaño, Alvaro, et al.
Publicado: (2018)

POST-COVID-19 ORGANIZING PNEUMONIA: A RARER ENTITY THAN PREVIOUSLY IMAGINED
por: OGBONNAH, UZOAMAKA, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS AND RISK FACTORS OF MORTALITY FOR HOSPITALIZED PATIENTS WITH CANCER WITH COVID-19 INFECTION IN MACCA, SAUDI ARABIA
por: GHALEB, N., et al.
Publicado: (2022)

GROUND GLASS OPACITIES: IT'S NOT ALL COVID
por: RAMIREZ, LEANDRO, et al.
Publicado: (2021)

POSTPARTUM COVID-19 COMPLICATED BY BLASTOMYCOSIS INFECTION
por: NASIM, RABAB, et al.
Publicado: (2021)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

LETHAL FUNGEMIA IN COVID-19 PNEUMONIA
por: PLEMMONS, ANNA, et al.
Publicado: (2021)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

MULTIPLE ORGAN SYSTEMS INVOLVEMENT IN COVID-19 IS ASSOCIATED WITH INCREASED IN MORTALITY
por: LAM, ERIC, et al.
Publicado: (2021)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

BILATERAL PNEUMOTHORACES IN A PATIENT WITH COVID PNEUMONIA
por: Ul Haq, Irfan, et al.
Publicado: (2020)

STREPTOCOCCUS ANGINOSUS LUNG ABSCESS WITH CORONAVIRUS 2019 PNEUMONIA
por: Kemnic, Tyler, et al.
Publicado: (2020)

CLINICAL OUTCOMES OF PATIENTS WITH ASTHMA WITH COVID-19 PNEUMONIA
por: Brinton, Taylor, et al.
Publicado: (2020)

RESTRICTIVE LUNG DEFECT IN POST-COVID-19 PNEUMONIA
por: TAWEESEDT, PAHNWAT, et al.
Publicado: (2021)

LEAKY LUNGS: A COMPLICATION OF COVID-19 PNEUMONIA
por: ADHIKARI, PRAKASH, et al.
Publicado: (2021)

ARDS IN CYSTIC FIBROSIS PATIENT WITH DOUBLE LUNG TRANSPLANT SURVIVES SARS-COV-2
por: Modugula, Sujith, et al.
Publicado: (2020)

IN VITRO TO IN VIVO: COMBATING MULTIDRUG-RESISTANT ENTEROBACTERIACAE IN THE AGE OF COVID-19
por: WALKER, CHRISTOPHER B, et al.
Publicado: (2022)

INFLAMMATORY MARKERS AS PREDICTORS OF INTUBATION IN PATIENTS WITH COVID-19
por: KUMAR, SANT, et al.
Publicado: (2021)

HORSES HAVE HOOVES TOO: A CASE OF MRSA PNEUMONIA
por: Avasarala, Amitha, et al.
Publicado: (2020)

GUILLAIN-BARRÉ SYNDROME FOLLOWING COVID-19 PNEUMONIA: ARE THEY RELATED?
por: THOMAS, AKESH, et al.
Publicado: (2021)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

DEXAMETHASONE-INDUCED HICCUPS IN A PATIENT WITH COVID-19 PNEUMONIA
por: HASIB KHALIL, MUHAMMAD
Publicado: (2021)

ROSEOMONAS GILARDII-ASSOCIATED BACTEREMIA IN THE SETTING OF COVID-19 PNEUMONIA
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

ABO BLOOD TYPES AND INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

COVID-19 PNEUMONIA: A CAUSE OF CAVITARY LUNG LESIONS
por: ANIS, KARIM H, et al.
Publicado: (2022)

A PATIENT WITH COVID-19 PNEUMONIA, PULMONARY EMBOLISM, AND OSA
por: SPACONE, ANTONELLA, et al.
Publicado: (2022)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

FIRST CASE OF COVID-19 COMPLICATED WITH BURKOLDERIA CEPACIA PNEUMONIA AND BACTEREMIA
por: Osman, Heba, et al.
Publicado: (2020)

PULMONARY CAVITARY TB IN A PATIENT WITH SARS COV 2 PNEUMONIA
por: Sasson, Arielle, et al.
Publicado: (2020)

LATENT MYCOBACTERIUM TB REACTIVATION IN TWO PATIENTS WITH COVID-19 PNEUMONIA
por: YOUNES, ISLAM, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34r4dt4gahbj8gvntpdfcs9t6s